跳至主要内容
临床试验/NCT01248104
NCT01248104已完成不适用

Comparison of Tranexamic to Epsilon Aminocaproic Acid: a Prospective Analysis of Blood Conservation in Cardiac Surgery

Loma Linda University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2010年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Total Transfusion Amounts

研究概览

简要总结

We designed a prospective double-blinded randomized trial in an attempt to detect a difference between tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) in reducing transfusion in patients undergoing cardiac surgery.

详细描述

Background: This study compares the efficacy of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) in reducing blood loss in patients undergoing cardiac surgery. Methods: This was a double-blinded randomized trial. Patients (n=100) undergoing cardi- ac surgery were randomized to receive either TXA (10 mg/kg bolus followed by an infu- sion of 1mg/kg/hr) or EACA (150mg/kg bolus followed by an infusion of 20 mg/kg/hr). The primary outcome measure was a difference in transfusion amounts.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Is the subject 18 years of age or older?
  • Is the subject scheduled for primary cardiac surgery utilizing cardiopulmonary bypass(CPB)?
  • Is the subject more than 30 kg ( 66 lbs)?
  • Does subject understand English?

排除标准

  • Does the subject have existing coagulation defects (INR > 1.5, platelets < 100 ?
  • Does the subject have renal failure (defined as BUN/Cr ratio 20:1 ?
  • Does the subject have severe liver disease (AST & ALT> 3x normal) ?
  • Is the subject having emergency cardiac surgery, complex aortic surgery, combination valve/CABG surgeries, or redo cardiac surgery?
  • Is the subject having any procedure where CPB is not anticipated?
  • Is the patient weight greater than 150 kg?

研究组 & 干预措施

Tranexamic Acid

Active Comparator

The research pharmacist used computer randomization to assign patients to receive either TXA or EACA. The TXA group re- ceived a bolus of 10 mg / kg over 15 minutes fol- lowed by an infusion of 1 mg/kg/hr.

干预措施: Tranexamic Acid (Drug)

Aminocaproic Acid

Active Comparator

The research pharmacist used computer randomization to assign patients to receive either TXA or EACA. The EACA group received a bolus of 100 mg / kg given over 15 minutes shortly after induction of anesthesia followed by an infusion of 10 mg/kg/hr.

干预措施: Aminocaproic Acid (Drug)

结局指标

主要结局

Total Transfusion Amounts

时间窗: 48 hours

The outcome measure was the intergroup difference in total transfusion amounts up to post-operative day 2.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jason Gatling, MD

MD

Loma Linda University

研究点 (1)

Loading locations...

相似试验